AIP
KRON

Ameritas Investment Partners’s Kronos Bio KRON Stock Holding History

Ameritas Investment Partners’s Portfolio KRON Stock Details KRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,044
Closed -$4.44K – 3164
2023
Q1 		$4.44K Hold
3,044
– – ﹤0.01% 2876
2022
Q4 		$7K Hold
3,044
– – ﹤0.01% 2873
2022
Q3 		$10K Hold
3,044
– – ﹤0.01% 2799
2022
Q2 		$11K Hold
3,044
– – ﹤0.01% 2811
2022
Q1 		$22K Hold
3,044
– – ﹤0.01% 2517
2021
Q4 		$41K Hold
3,044
– – ﹤0.01% 2256
2021
Q3 		$64K Hold
3,044
– – ﹤0.01% 1990
2021
Q2 		$73K Buy
3,044
+1,820
+149% +$46.1K ﹤0.01% 1929
2021
Q1 		$36K Hold
1,224
– – ﹤0.01% 2274
2020
Q4 		$37K Buy
+1,224
New +$38.4K ﹤0.01% 2157

Other funds holding KRON

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VVA
Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
PCIG
Partners Capital Investment Group Boston, Massachusetts $2.65B AUM 16.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Ameritas Investment Partners's KRON Position: Q2 2023 in Review

Ameritas Investment Partners sold out of Kronos Bio (KRON) in Q2 2023, closing a stake of 3,044 shares — an estimated $4.44K sold.

Ameritas Investment Partners first reported a position in KRON in Q4 2020 and held it in 10 quarters. The position peaked at $73K in Q2 2021. 80 funds tracked by Wall St. Rank hold KRON as of Q2 2023.

  • Ameritas Investment Partners reported no remaining Kronos Bio position as of Q2 2023 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,044 Kronos Bio shares in Q2 2023, an estimated $4.44K.
  • Ameritas Investment Partners first reported a position in Kronos Bio in Q4 2020 and held it in 10 quarters.
  • Ameritas Investment Partners's Kronos Bio position peaked at $73K in Q2 2021.
  • 80 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2023.

Based on Ameritas Investment Partners's 13F filing for Q2 2023, filed 11 Aug 2023.